SELLAS Life Sciences (SLS) Enterprise Value (2019 - 2024)
Historic Enterprise Value for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to -$21.0 million.
- SELLAS Life Sciences' Enterprise Value fell 42577.5% to -$21.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$21.0 million, marking a year-over-year decrease of 42577.5%. This contributed to the annual value of -$2.5 million for FY2023, which is 8522.63% up from last year.
- Latest data reveals that SELLAS Life Sciences reported Enterprise Value of -$21.0 million as of Q3 2024, which was down 42577.5% from -$9.1 million recorded in Q2 2024.
- SELLAS Life Sciences' Enterprise Value's 5-year high stood at -$2.5 million during Q4 2023, with a 5-year trough of -$35.3 million in Q4 2020.
- Its 5-year average for Enterprise Value is -$17.5 million, with a median of -$18.4 million in 2024.
- As far as peak fluctuations go, SELLAS Life Sciences' Enterprise Value plummeted by 79571.86% in 2021, and later skyrocketed by 8522.63% in 2023.
- Quarter analysis of 5 years shows SELLAS Life Sciences' Enterprise Value stood at -$35.3 million in 2020, then skyrocketed by 39.51% to -$21.4 million in 2021, then rose by 19.81% to -$17.1 million in 2022, then skyrocketed by 85.23% to -$2.5 million in 2023, then crashed by 731.26% to -$21.0 million in 2024.
- Its last three reported values are -$21.0 million in Q3 2024, -$9.1 million for Q2 2024, and -$18.4 million during Q1 2024.